Anginova Lozenges
Dequalinium Chloride, Lidocaine HCl
"0.25mg, 1mg"
MEDINOVA LTD.
| Pack size | 20's (10's Blister x 2) |
|---|---|
| Dispensing mode | P |
| Source | SWITZERLAND |
| Agent | NEW MEDICAL CENTRE |
| Retail Price | AED |
Indications
Anginova Lozenges is used for:
DEQUALINIUM
It is used in wound dressings and mouth infections and may also have antifungal action. It may cause skin ulceration
LIDOCAINE
For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks
It is used in wound dressings and mouth infections and may also have antifungal action. It may cause skin ulceration
LIDOCAINE
For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Dequalinium Chloride, Lidocaine HCl :
Mechanism of Action
LIDOCAINE
Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. Lidocaine alters signal conduction in neurons by blocking the fast voltage gated sodium (na+) channels in the neuronal cell membrane that are responsible for signal propagation. With sufficient blockage the membrane of the postsynaptic neuron will not depolarize and will thus fail to transmit an action potential. This creates the anaesthetic effect by not merely preventing pain signals from propagating to the brain but by aborting their birth in the first place
Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. Lidocaine alters signal conduction in neurons by blocking the fast voltage gated sodium (na+) channels in the neuronal cell membrane that are responsible for signal propagation. With sufficient blockage the membrane of the postsynaptic neuron will not depolarize and will thus fail to transmit an action potential. This creates the anaesthetic effect by not merely preventing pain signals from propagating to the brain but by aborting their birth in the first place
Note
Anginova "0.25mg, 1mg" Lozenges manufactured by MEDINOVA LTD.. Its generic name is Dequalinium Chloride, Lidocaine HCl. Anginova is availble in United Arab Emirates.
Farmaco UAE drug index information on Anginova Lozenges is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.